Efficacy and safety of short-term (≤6 months) duration of dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomized controlled trials [Anatol J Cardiol]
Efficacy and safety of short-term (≤6 months) duration of dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomized controlled trials
Chun - Lin Xiang1, Yi - Zhen Gong2, Long - Jia Zeng3, Bei - Bei Luo1, Jian Xu1, Yan He11Departments of Geriatric Cardiology, the First Affiliated Hospital of Guangxi Medical University; Nanning, Guangxi-People’s Republic of China 2Evidence-based Medicine, the First Affiliated Hospital of Guangxi Medical University; Nanning, Guangxi-People’s Republic of China 3Obstetrics and Gynecology, the First Affiliated Hospital of Guangxi Medical University; Nanning, Guangxi-People’s Republic of China Keywords: antiplatelet therapy, coronary artery disease, drug-eluting stent
Chun - Lin Xiang, Yi - Zhen Gong, Long - Jia Zeng, Bei - Bei Luo, Jian Xu, Yan He. Efficacy and safety of short-term (≤6 months) duration of dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomized controlled trials. Anatol J Cardiol. 2017; 17(3): 168-175
Corresponding Author: Yan He, China Manuscript Language: English